Non-alcololic fatty liver disease (NAFLD) has a great concern in regards to liver transplantation (LT); from becoming the second most common cause of of transplant candidates due to its high worldwide prevalence and from the other hand, the urgent need for increasing the donor pool by using marginal donors with graft steatosis, especially in living donor LT. It has been postulated that steatotic livers are more sensitive and less tolerant to ischaemia-reperfusion (I/R) injury, leading to worse clinical outcomes. If severe, I/R injury can lead to liver failure and death.